Navigation Links
Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
Date:3/10/2008

th new HIV drugs approved by the FDA in 2007," said Bill Young, Monogram's chief executive officer. "We are delighted to work with Avexa on their exciting development programs, and to build international partnerships that bring truly global cooperation and innovation to the fight against HIV."

As recommended by the U.S. FDA Antiviral Drugs Advisory Committee, biopharmaceutical companies are using HIV resistance testing technology to support and enhance next-generation HIV drug development. Monogram's proprietary technology is being applied to new HIV drug targets for screening and in subsequent clinical development programs for optimization of background therapy, patient monitoring and, in the case of CCR5 antagonists, for patient selection.

About Monogram

Monogram is a biotechnology company advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com.

About Avexa

Avexa Limited is a Melbourne, Australia-based biotechnology company with a focus on research and development of drugs for the treatment of infectious diseases. Avexa has dedicated resources and funding for key projects including its HIV integrase program and an antibiotic program for antibiotic-resistant bacterial infections. The Company's lead program is apricitabine (ATC), an anti-HIV drug which has successfully completed the 48 week dosing of its Phase 2b trial and has
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
2. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
3. Monogram Biosciences to Present at the JMP Securities Healthcare Conference
4. Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call
5. Monogram Announces Third Quarter 2007 Financial Results
6. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
8. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015   Intrexon Corporation ... today that Gregory Frost , Ph.D., Senior Vice President ... Jefferies 2015 Global Healthcare Conference on Wednesday, June 3 rd ... in New York City . ... ) is Powering the Bioindustrial Revolution with Better DNA ™ ...
(Date:5/26/2015)...   PDI , a leader in infection ... Healthcare in Dearborn, Mich. ... Delivering the Difference , a ... building collaborative relationships between infection prevention (IP) and ... Oakwood Healthcare,s infection preventionist, Priscila ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Mr. ... his family, thanks President Barack Obama and President ... during the time of loss of Dr. Rongxiang Xu ... humanitarian and a leader ahead of his time, Dr. Xu,s ... the community leave a legacy that will not be forgotten. ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 US-Australian drug ... announced today that it will present at the 2015 Marcum ... New York City at the Grand Hyatt Hotel. ... Novogen Chairman and CEO, is scheduled to begin at 9.30 a.m. ... the webcast, go to http://wsw.com/webcast/marcum3/nvgn . The ...
Breaking Biology Technology:Intrexon to Present at the Jefferies 2015 Global Healthcare Conference 2PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, Beyond A Legend 2Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4
... HARBIN, China, Aug. 14 /PRNewswire-Asia-FirstCall/ -- ... Company") (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... financial results for the second quarter,of 2009. , , ... Total revenues increased 35.5% year-over-year to $32.2 million, ...
... 14 /PRNewswire-Asia-FirstCall/ -- Tiens Biotech Group (USA),Inc. (the "Company" or "Tiens"; ... financial results for the second quarter and six months ended,June 30, ... of 2009 increased 4.6% to $20.6 million,compared to $19.7 million for ... , Net income for the quarter rose ...
... ... Website in an effort to not only provide circuit board assembly and design services, but ... ... their current and future customers Surface Mount Solutions (SMS) has launched a new Web 2.0 ...
Cached Biology Technology:China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 2China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 3China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 4China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 5China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 6China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 7China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 8China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 9China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 10China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results 11Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 2Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 3Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 4Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 5Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 6Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 7Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 8Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 9Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 10Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 11Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results 12Surface Mount Solutions Launches New Website 2
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... OXFORD, Conn. , May 20, 2015 ... "Company") announces that its wholly owned subsidiary, 3D-ID LLC, ... contractor under Team Battelle for the biometrics technology portion ... Unrestricted Suite Contract from the Department of the Army. ... facial recognition products developed for government, law enforcement and ...
(Date:5/19/2015)... , May 19, 2015  Technology is rapidly advancing, ... and in the cloud. Passwords and their management are ... OTP and standards-based specifications such as those developed by ... use of passwords presents for BYOD, COPE, IoT, and ... biometric identity protocol. In response to ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... University biologists are part of an international research team ... remote Arctic lake provides compelling evidence of unprecedented environmental ... "Our findings show that the last several decades have ... Neal Michelutti, a research scientist at the Paleoecological Environmental ...
... An analysis of sediment cores indicates that biological and chemical ... the past 200,000 years and likely are the result of ... the University of Colorado at Boulder. While environmental ... shown to be tightly linked with natural causes of climate ...
... new ways to fight cancer and other diseases have ... circadian rhythm, says Liheng Shi, a researcher in Texas ... the roughly 24-hour cycle of physiological activities of humans, ... have had their research, currently focusing on the circadian ...
Cached Biology News:Queen's scientists on international team discover 'ecologically unique' changes in Arctic lake 2Arctic lake sediments show warming, unique ecological changes in recent decades 2Arctic lake sediments show warming, unique ecological changes in recent decades 3Texas A&M researchers find new mechanism for circadian rhythm 2
Recombinant Feline IL-5...
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
Recombinant Feline IL-2, CF...
Recombinant Equine IL-4, CF...
Biology Products: